IRF-6 Antibody#6948,Cell Signaling Technology (CST),6948

IRF-6 Antibody recognizes endogenous levels of total IRF-6 protein.

Reactivity

Human

Application

Western Blotting: 1:1000 Immunoprecipitation: 1:100

Platform ID

BAB858467262

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NameIRF-6 Antibody#6948
Cat. No.6948
Accession NumberO14896
Gene ID (Entrez)14896, 3664
SensitivityEndogenous
ReactivityHuman
ApplicationWestern Blotting: 1:1000 Immunoprecipitation: 1:100
Molecular Weight58, 60
FormulationSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.
StorageSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.
Regulatory StatusResearch Use Only

Scientific Background

Interferon regulatory factors (IRFs) comprise a family of transcription factors that function within the Jak/Stat pathway to regulate interferon (IFN) and IFN-inducible gene expression in response to viral infection (1). IRFs play an important role in pathogen defense, autoimmunity, lymphocyte development, cell growth, and susceptibility to transformation. The IRF family includes nine members: IRF-1, IRF-2, IRF-9/ISGF3γ, IRF-3, IRF-4 (Pip/LSIRF/ICSAT), IRF-5, IRF-6, IRF-7, and IRF-8/ICSBP. All IRF proteins share homology in their amino-terminal DNA-binding domains. IRF family members regulate transcription through interactions with proteins that share similar DNA-binding motifs, such as IFN-stimulated response elements (ISRE), IFN consensus sequences (ICS), and IFN regulatory elements (IRF-E) (2).While IRF family members generally function in innate immune responses, IRF-6 has not been associated with that role. Original studies of IRF-6 found that mutation of theIRF-6gene caused Van der Woude Syndrome, an autosomal dominant disorder resulting in mouth abnormalities, including cleft lip and palate (3). IRF-6 knockouts show a hyperproliferative epidermis that fails to undergo keratinocyte differentiation (4). IRF-6 has also been found to interact with the mammary tumor suppressor maspin, and like maspin, is expressed in normal mammary epithelial cells but reduced or absent in breast carcinoma (5). Cellular proliferation may promote IRF-6 phosphorylation, leading to proteasomal-dependent degradation (6).Taniguchi, T. et al. (2001)Annu Rev Immunol19, 623-55.Honda, K. and Taniguchi, T. (2006)Nat Rev Immunol6, 644-58.Kondo, S. et al. (2002)Nat Genet32, 285-9.Richardson, R.J. et al. (2006)Nat Genet38, 1329-34.Bailey, C.M. et al. (2005)J Biol Chem280, 34210-7.Bailey, C.M. et al. (2008)Mol Cell Biol28, 2235-43.Alternate NamesInterferon regulatory factor 6; IRF-6; IRF6; LPS; OFC6; PIT; PPS; PPS1; VWS; VWS1

Synonyms

Interferon regulatory factor 6; IRF-6; IRF6; LPS; OFC6; PIT; PPS; PPS1; VWS; VWS1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.